87093137 - OXITRAN

Information

  • Trademark
  • 87093137
  • Serial Number
    87093137
  • Registration Number
    5239739
  • Filing Date
    July 05, 2016
    8 years ago
  • Registration Date
    July 11, 2017
    7 years ago
  • Transaction Date
    March 05, 2024
    a year ago
  • Status Date
    January 26, 2024
    a year ago
  • Published for Opposition Date
    March 07, 2017
    8 years ago
  • Location Date
    July 11, 2017
    7 years ago
  • Status Code
    710
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    MARESCA, MEREDITH Z
  • Attorney Docket Number
    1439095.4019
    Attorney Name
    Maria A. Scungio
    Law Office Assigned Location Code
    L90
  • Owners
Mark Drawing Code
4000
Mark Identification
OXITRAN
Case File Statements
  • GS0051: Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of neuromuscular and ophthalmological diseases; Pharmaceutical preparations for the treatment of central nervous system-related conditions, neurological and muscular diseases, neuro-muscular diseases, muscular dystrophies, ataxias, amyotrophia, atrophy, ophthalmological diseases, muscle wasting, cardiomyopathies, optic nerve degradation, neurological indications, memory loss, Lou Gehrig's disease, Parkinson's disease, Huntington's disease, spinal muscular atrophies, polyneuropathies, fibromyalgia, mononeuropathies, neuromuscular junction disorders, myotonia and myopathies; reagents for medical use in connection with the aforementioned diseases
  • GS0011: Active chemical ingredients for use in the manufacture of small molecule pharmaceuticals for treating neuromuscular and ophthalmological diseases; reagents for scientific and medical research for use in the research of small molecule pharmaceuticals and research of the treatment of neuromuscular and ophthalmological diseases; all of the foregoing excluding cleaning agents for use in laboratories and industries
  • GS0421: Medical research; scientific research; medical and scientific research, namely, conducting clinical trials for others; computer programming for others for medical and science research purposes; scientific research for testing cell cultures and developing cellular test systems for evaluating new drugs and antibodies; developing test systems for detecting pharmacologically active compounds; genetic animal model testing and scientific research for neuro-muscular and ophthalmological diseases for research purposes
Case File Event Statements
  • 1/26/2024 - a year ago
    36 - CANCELLED SEC. 8 (6-YR) Type: C8..
  • 7/11/2022 - 2 years ago
    35 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1
  • 6/20/2018 - 6 years ago
    34 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 6/20/2018 - 6 years ago
    33 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 7/11/2017 - 7 years ago
    32 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 6/2/2017 - 8 years ago
    31 - 1(B) BASIS DELETED; PROCEED TO REGISTRATION Type: DP1B
  • 5/11/2017 - 8 years ago
    30 - NOTICE OF ALLOWANCE CANCELLED Type: IUCN
  • 6/2/2017 - 8 years ago
    29 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 5/11/2017 - 8 years ago
    28 - TEAS POST PUBLICATION AMENDMENT RECEIVED Type: EPPA
  • 5/2/2017 - 8 years ago
    27 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 3/7/2017 - 8 years ago
    26 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 3/7/2017 - 8 years ago
    25 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 2/15/2017 - 8 years ago
    24 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 1/31/2017 - 8 years ago
    23 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 1/25/2017 - 8 years ago
    22 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 1/24/2017 - 8 years ago
    21 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 1/24/2017 - 8 years ago
    20 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 1/17/2017 - 8 years ago
    19 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 12/29/2016 - 8 years ago
    18 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 12/29/2016 - 8 years ago
    17 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 12/29/2016 - 8 years ago
    16 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 12/29/2016 - 8 years ago
    15 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX
  • 12/23/2016 - 8 years ago
    14 - ASSIGNED TO LIE Type: ALIE
  • 11/17/2016 - 8 years ago
    13 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 11/17/2016 - 8 years ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 11/17/2016 - 8 years ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 11/1/2016 - 8 years ago
    10 - ASSIGNED TO LIE Type: ALIE
  • 10/26/2016 - 8 years ago
    9 - ASSIGNED TO LIE Type: ALIE
  • 10/18/2016 - 8 years ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 10/18/2016 - 8 years ago
    7 - NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED Type: GEAN
  • 10/18/2016 - 8 years ago
    6 - EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED Type: GEAP
  • 10/18/2016 - 8 years ago
    5 - COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY Type: EPEN
  • 10/18/2016 - 8 years ago
    4 - EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED Type: CPEA
  • 10/13/2016 - 8 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/8/2016 - 8 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 7/8/2016 - 8 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP